Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.US-based Medline Industries has signed an exclusive marketing and distribution agreement with ACell, a regenerative medicine company, for its MatriStem wound care matrix. Under the agreement, ACell will manufacture and Medline will market and distribute the products.
Subscribe to our email newsletter
ACell’s MatriStem regenerative medicine technology is a naturally occurring bioscaffold derived from porcine tissue. When MatriStem is placed onto a wound, it is resorbed and replaced with new native tissue where scar tissue would normally be expected.
MatriStem Wound Care Matrix facilitates the healing process and is used on partial and full-thickness wounds such as diabetic, venous, arterial and pressure ulcers, and first and second-degree burns, the two companies said.
Jim DeFrancesco, president and CEO of ACell, said: “As an advanced wound care company, Medline will be an excellent partner for marketing and distributing our MatriStem wound care matrix. We look forward to utilizing our unique regenerative medicine technologies in future collaborative efforts with Medline for creating additional advanced wound care products.”